🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
When a patient with Parkinson's disease (PD) is initially treated with L-do...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-14
Trial ID
NCT01155466
This study was designed to determine if preladenant (SCH 420814, MK-3814) c...
Status
Terminated
Location
Multiple Locations
Start Date
2006-07-10
Trial ID
NCT00686699
Treatments Being Tested
This is a study of the efficacy and safety of preladenant in adult particip...
Status
Completed
Location
Multiple Locations
Start Date
2010-11-19
Trial ID
NCT01227265
Treatments Being Tested
This is a two part study to compare the PK of preladenant administered to p...
Status
Completed
Location
Multiple Locations
Start Date
2011-03-28
Trial ID
NCT01323855
Treatments Being Tested
The purpose of the study is to assess the efficacy and safety of a range of...
Status
Completed
Location
Multiple Locations
Start Date
2006-11-20
Trial ID
NCT00406029
The purpose of this study is to assess the long term safety of SCH 420814 (...
Status
Completed
Location
Multiple Locations
Start Date
2007-11-23
Trial ID
NCT00537017
Treatments Being Tested
This study is designed to evaluate the effectiveness of preladenant in the ...
Status
Terminated
Location
Multiple Locations
Start Date
2007-08-15
Trial ID
NCT00693472
Treatments Being Tested
This study is to evaluate the efficacy of a range of preladenant doses comp...
Status
Completed
Location
Multiple Locations
Start Date
2011-02-25
Trial ID
NCT01294800
Treatments Being Tested
This is a one year, 2-part study to determine the efficacy and safety of pr...
Status
Terminated
Location
Multiple Locations
Start Date
2010-07-06
Trial ID
NCT01155479
The purpose of this study is to evaluate the safety and preliminary efficac...
Status
Terminated
Location
START Midwest ( Site 0001)
Start Date
2017-06-27
Trial ID
NCT03099161
Treatments Being Tested